NYSE: THC

Tenet Healthcare (THC) Stock Analysis & Forecast

Nov 13 close

$286.03−0.83 (−0.3%)

Gekko Brief

AI summaryNov 9 close

Tenet Healthcare shares have moved higher this week after the company reported Q3 2026 results of $5,631 million in sales and $1,000 million in net income, prompting raised full-year 2026 guidance for net operating revenues of $22,050 million to $22,450 million and diluted EPS of $35.82 to $37.08. The report drew a string of positive commentary, with some coverage noting the stock trades at roughly 7.9x earnings versus a sector average of 25.8x, and analyst actions followed, including Barclays reiterating an Overweight rating and raising its price target to $297 from $271, and Argus lifting its target to $293.00. Shares also moved with broader healthcare peers after election results confirmed Democratic majorities in the House and Senate.

THC closed at $289.00, up 2% on the day, and sits above both its 50-day average of $265.80 and 200-day average of $222.84, with the 50-day above the 200-day. The GekkoIndex reads 48.9, placing it in the Neutral zone, down 5.9 points over the past five readings. Price sits 3.4% below Gekko Fair Value of $299.32.

The next earnings report is scheduled for 10 February 2027, 92 days out, beyond a typical 20-trading-day hold. No insider, Congress, or unusual options activity appears in their respective windows. Seasonally, the next 20 trading days have averaged a 3.8% gain over five years, rising in four of them. Analyst consensus stands at 13 buy, 2 hold, 0 sell ratings, with a consensus target of $304.14, about 5.2% above current levels.

Written by AI from the Nov 9, 2026 close and checked automatically against the figures on this page.

Tenet Healthcare price vs fair value

$295.02$286.03Nov ’25May ’26Nov ’26
Close $286.03200-day averageGekko Fair Value $295.02

Tenet Healthcare quick facts

Market cap
$22.76B
P/E ratio
8.3
Forward P/E
15.1
EPS, TTM
$34.29
Revenue, TTM
$22.15B
Profit margin
13.1%
Dividend yield
—
Beta
1.20
Volume
370,976 avg 899,892
1-year return
+43.0%
Typical daily move
±4.6%
Typical 20-day move
±8.3%
50-day average
$267.85
200-day average
$224.83
Next earnings
Feb 10
Shares outstanding
79.59M
52-week range
$157.58$301.44

Tenet Healthcare swing-trade checklist

Tenet Healthcare scores 3 supportive, 2 mixed and 0 headwinds across the 5 checklist items with data.

Six things swing traders check before a 20-day hold, read from the latest data.

3 supportive2 mixed0 headwinds

  • Trendsupportive

    Above 50 and 200-day

    Close $286.03 is above the 50-day ($267.85) and 200-day ($224.83) averages, and the 50-day is above the 200-day.

    See the chart
  • GekkoIndexmixed

    52.8, Neutral

    Reading 52.8 is in the Neutral zone.

    See the GekkoIndex
  • Fair valuemixed

    3.0% below

    Price is within 5% of Gekko Fair Value (3% below).

    See fair value
  • Smart moneyno data

    No data

    No insider, Congress or unusual options activity in the window.

    See smart money
  • Earnings risksupportive

    Reports in 87 days

    Next report Feb 10, 2027, 87 days away — outside a typical 20-trading-day hold.

    See earnings
  • Seasonalitysupportive

    +3.5% on average

    From this point in the calendar, the next 20 trading days averaged +3.5% over 5 years, rising in 3 of them.

    See seasonality

A description of current data, not a recommendation. How this page works

Tenet Healthcare stock chart and price history

Tenet Healthcare closed at $286.03 on Nov 13, 2026, +43.0% over the past year, inside a 52-week range of $157.58 to $301.44.

Close50-day average200-day averageVolume
Tenet Healthcare share price, past year, with 50-day and 200-day moving averages and volume$175$200$225$250$275$300DecJan 2026FebMarAprMayJunJulAugSepOctNov286.03

Use the left and right arrow keys to read daily values.

Performance Breakdown

1 month
+4.0%
3 months
+8.1%
6 months
+45.4%
1 year
+43.0%
The full THC chart adds GekkoIndex, insider, options, Congress and hedge fund markers, plus TrendCandles™.Open THC in Gekko

Follow Tenet Healthcare through every session

Put THC on a Gekko watchlist and see its GekkoIndex, Gekko Fair Value and smart money signals update on the chart as they change.

Track THC in GekkoFree for 7 days. No credit card required.

About Tenet Healthcare

Tenet Healthcare provides a wide range of medical services through hospitals and related clinical sites. Its acute care facilities cover core hospital functions such as surgery and recovery, radiology, respiratory therapy, laboratory work, and pharmacy services, along with intensive and coronary care units. The company also handles specialized treatment in areas like cardiovascular care, digestive disease, neurosciences, musculoskeletal conditions, and obstetrics, extending into advanced procedures including cardiothoracic and neurosurgery, organ transplants, trauma care, stroke treatment, and telemedicine.

Tenet organizes its work into three segments: Hospital Operations and Other, Ambulatory Care, and Conifer. The Ambulatory Care side runs outpatient surgical centers, urgent care sites, imaging centers, and micro-hospitals, while Conifer supplies business process support to hospitals, health systems, physician practices, and employers, covering revenue cycle management, patient communication, and care outcome services.

Tenet Healthcare was founded in 1975 and is headquartered in Dallas, Texas. Its shares are listed on the NYSE under the ticker THC.

Listed
NYSE
Sector
Health services
Industry
Hospital/Nursing management
Website
tenethealth.com

Tenet Healthcare GekkoIndex: the smart money zone

Tenet Healthcare’s GekkoIndex — Gekko’s 0 to 100 smart money score — reads 52.8, in the Neutral zone, up 3.3 points over five sessions.

010052.8Neutral

Up 3.3 points over five sessions.

Reading for Nov 13, 2026

What followed past readings in each zone

ZoneReadings5 days10 days20 days50 days
Buying28+2.5%+5.4%+10.9%+13.0%
Accumulation170+1.2%+3.5%+5.4%+11.9%
Neutral (current zone)446+1.1%+1.4%+2.9%+9.8%
Distribution55+0.2%+2.1%+6.4%+4.4%
Selling3Too few readings yet

Average THC share-price change over the trading days after each daily reading in its GekkoIndex history. Across every stock Gekko tracks, Neutral readings averaged +0.9% over 20 days. Past behaviour doesn’t guarantee future results.

Neutral zone: No clear directional signal. About the five zones →

See every daily GekkoIndex reading plotted over the THC price, zone by zone.Track THC in Gekko

Is Tenet Healthcare stock overvalued? Gekko Fair Value

Tenet Healthcare trades 3.0% below Gekko Fair Value of $295.02, so the shares are about fair value on Gekko’s estimate.

Gekko’s own estimate of what Tenet Healthcare shares are worth, recalculated every trading day.

$295.02

Gekko Fair Value, Nov 14, 2026

3.0% below fair value · About fair value

At the end of Aug 2026 the price was 7.4% below the estimate.

Gekko Fair ValueShare price, month end
$295$286Aug 2026SepOctNov 2026

How Gekko Fair Value works →

Gekko Fair Value on every chart, with the gap to price updating daily.Open THC in Gekko

Tenet Healthcare insider and Congress trading

No open-market insider purchases were filed for Tenet Healthcare, and no Congress trades were disclosed, in the last 90 days.

Plus buybacks, unusual options and fund positions, each dated to when it became public.

Insider buying last 90 days

No open-market insider purchases were filed for THC in the last 90 days.

From Form 4 filings, dated to when each was filed.

Every THC insider filing, plotted on the chart in Gekko.Open THC in Gekko

Congress trades last 90 days

No trades in THC were disclosed by members of Congress in the last 90 days.

From congressional disclosures, which report amounts as ranges.

Congress disclosures for THC, plotted on the chart in Gekko.Open THC in Gekko

Buybacks

Tenet Healthcare has been buying back its own shares.

Bought back, quarter ended Sep 30, 2026
$255.0M
As a share of market cap
1.12%
Trailing four quarters
$1.82B

From company filings.

Hedge funds and billionaires quarter ended Jun 30

1of the funds Gekko tracks holds THC.

1added0opened0trimmed2sold out
Which funds are on each side, name by name.Unlock in Gekko

Tenet Healthcare earnings: next date and track record

Tenet Healthcare reports on Feb 10, 2027 (87 days away), and beat the EPS estimate in 8 of its last 8 reports.

8 of 8reports beat the EPS estimate
±10.8%average move across the report
5 of 8reports followed by a gain

Share-price move across each report

+13.3%Oct ’24−3.8%Feb ’25+15.4%Apr ’25−9.4%Jul ’25−3.3%Oct ’25+20.3%Feb ’26+1.8%Apr ’26+19.4%Jul ’26

Last earnings call, Jul 23, 2026 AI summary

What they said
Tenet Healthcare reported Q2 2026 net operating revenues of $5.6 billion and consolidated adjusted EBITDA of $1.304 billion (23.2% margin), up 16.3% year-over-year. Adjusted diluted EPS surged 52% to $6.12. USPI generated $542 million in EBITDA (9% growth), while hospital segment EBITDA reached $762 million (22% growth). Exchange revenues declined 17% YoY, but technology-enabled cost management and high-acuity strategy offset headwinds. THC repurchased $1.36 billion in shares and authorized an additional $2 billion buyback.
Guidance
Management raised full-year 2026 revenue, adjusted EBITDA, and cash flow guidance. Continued share repurchase activity expected throughout the year. Optimistic outlook driven by volume growth, expense discipline, and high-acuity strategy despite ongoing exchange enrollment uncertainty.
ReportedEPSSurpriseRevenueSurpriseMove
Jul 23, 2026$6.12
est $4.26
+43.7%$5.63B
est $5.43B
+3.6%+19.4%
Apr 30, 2026$4.82
est $4.17
+15.6%$5.37B
est $5.39B
−0.5%+1.8%
Feb 11, 2026$4.70
est $4.07
+15.5%$5.53B
est $5.47B
+1.0%+20.3%
Oct 28, 2025$3.70
est $3.34
+10.8%$5.29B
est $5.26B
+0.6%−3.3%
Jul 22, 2025$4.02
est $2.87
+40.1%$5.27B
est $5.16B
+2.1%−9.4%
Apr 29, 2025$4.36
est $3.13
+39.3%$5.22B
est $5.14B
+1.6%+15.4%
Feb 12, 2025$3.44
est $2.83
+21.5%$5.07B
est $5.17B
−1.9%−3.8%
Oct 29, 2024$2.93
est $2.37
+23.6%$5.12B
est $5.05B
+1.5%+13.3%

“Move” is the close of the first session after the report compared with the close of the last session before it, so it reads the same whether the company reported before the open or after the close.

Tenet Healthcare stock forecast and analyst price targets

Analysts’ average 12-month price target for Tenet Healthcare is $307.32, +7.4% from the last close, from 16 firms rating the stock in the last 90 days.

$307.32consensus 12-month target, +7.4% from the last close
Low $265High $342
Buy14
Hold2
Sell0

Each firm’s latest rating in the last 90 days: 16 firms.

Latest analyst actions

DateFirmRatingTargetvs price
Nov 11Mizuho SecuritiesBuy, maintained$330+15.4%
Nov 10Goldman SachsBuy, maintained$320+11.9%
Nov 5Bank of America SecuritiesBuy, maintained——
Nov 4BarclaysBuy, maintained$297+3.8%
Nov 3KeyBancBuy, maintained$300+4.9%
+2.9%average 20-day move after past Neutral readings
+3.5%average move over the next 20 trading days in the last 5 years
±4.6%typical daily move, from the 14-day average range

Gekko doesn’t publish price predictions. These are analyst targets and historical base rates, which don’t guarantee future results.

Tenet Healthcare seasonality: the next 20 trading days

Over the next 20 trading days from Nov 14, Tenet Healthcare averaged +3.5% across the last 5 years, rising in 3 of them.

Next 20 trading days, by year

−4.9%2021+9.8%2022+27.0%2023−15.9%2024+2.3%2025

Average move and hit rate

WindowAverageYears higher
Next 5 trading days+1.3%2 of 5
Next 10 trading days+2.2%3 of 5
Next 15 trading days+1.9%3 of 5
Next 20 trading days+3.5%3 of 5
Next 30 trading days+5.1%4 of 5

For scale, THC’s typical 20-trading-day move in either direction is about 8.3%.

Tenet Healthcare market cap and key statistics

Tenet Healthcare’s market cap is $22.76B, with a P/E ratio of 8.3 and revenue of $22.15B over the last twelve months.

Valuation

Market cap
$22.76B
P/E ratio
8.3
Forward P/E
15.1
EPS, TTM
$34.29
Gekko Fair Value
$295.02

Trading

Volume
370,976
Avg volume, 20 days
899,892
52-week high
$301.44
52-week low
$157.58
Shares outstanding
79.59M

Financials

Revenue, TTM
$22.15B
Profit margin
13.1%
Return on equity
41.7%
Quarterly earnings growth, YoY
+221.5%

Risk and income

Beta
1.20
Typical daily move
±4.6%
Typical 20-day move
±8.3%

Tenet Healthcare stock news this week

Coverage of Tenet Healthcare this week reads positive: 4 positive, 2 neutral and 1 negative headlines.

News sentiment positive

Tenet Healthcare peers

Tenet Healthcare’s 6 largest industry peers by market value, with today’s move, GekkoIndex zone and gap to Gekko Fair Value.

StockTodayGekkoIndex zonevs Fair Value
HCAHCA Healthcare−1.1%Neutral26.1% above
UHSUniversal Health Services+1.0%Neutral11.5% below
PACSPACS0.0%Neutral6.5% below
CHEChemed−0.8%Neutral2.8% below
SGRYSurgery Partners+1.1%Distribution45.2% above
NHCNational HealthCare−1.6%Accumulation18.9% above

A peer links to its own page where one exists.

In the Buying zone today

Reporting earnings this week

Popular on Gekko

More stocks in Hospital/Nursing management

Tenet Healthcare stock FAQ

What is Tenet Healthcare’s market cap?

Tenet Healthcare’s market cap is $22.76B at the Nov 13, 2026 close of $286.03, with 79.59M shares outstanding. The shares trade on a P/E ratio of 8.3.

What is the Tenet Healthcare stock forecast?

The consensus analyst 12-month price target for Tenet Healthcare is $307.32, +7.4% from the last close. Of the 16 firms that rated the stock in the last 90 days, 14 rate it a buy, 2 a hold and 0 a sell. Gekko doesn’t publish price predictions of its own.

Is Tenet Healthcare stock overvalued or undervalued?

On Gekko’s estimate Tenet Healthcare is about fair value: the Nov 13, 2026 close of $286.03 is 3.0% below Gekko Fair Value of $295.02. Gekko Fair Value is recalculated every trading day, and a gap inside 5% either way counts as about fair value.

When does Tenet Healthcare report earnings next?

Tenet Healthcare is expected to report on Feb 10, 2027 (87 days away). Analysts expect earnings of $5.36 per share on revenue of $5.68B. Tenet Healthcare beat the earnings estimate in 8 of its last 8 reports, moving 10.8% on average across the report.

What is Tenet Healthcare’s 52-week high and low?

Tenet Healthcare’s 52-week high is $301.44 and its 52-week low is $157.58; it closed at $286.03 on Nov 13, 2026, +43.0% over the past year.

Is Tenet Healthcare stock a buy right now?

Gekko describes the data; it does not make buy or sell recommendations. On the swing-trade checklist, 3 of the 5 items with data read as supportive (trend, earnings risk and seasonality), 2 as mixed (gekkoindex and fair value). The checklist is a description of current data, not a recommendation.

How this page works

During US trading hours the price at the top of the page is a delayed quote, refreshed every 15 minutes; everything else is rebuilt after each US market close. The GekkoIndex, Gekko Fair Value and the checklist are Gekko’s own, and the Gekko Brief is written by AI from this page’s data and checked against it before it is published. How Gekko’s data works →

See Tenet Healthcare the way Gekko members do

Every GekkoIndex reading, insider trade, options bet and Congress disclosure plotted on the chart, plus the 5,800-name screener and trade planning tools.

Join 1,475 other traders using Gekko

Start Your FREE 7 Day Trial → Every feature unlocked. No credit card required.